Conferences
WuXi Seminar | Beyond Small Molecules – DMPK for New Modalities
-
Wed, 5 Mar 2025 11:00 - 14:00 CET
-
Lieden, The Netherlands
Join our event at Leiden on March 5th, 2025, for a forward-looking presentation on DMPK's pivotal role in accelerating next-generation drug development. Delve into tailored strategies for novel modalities—oligonucleotides, ADCs, biologics, and more. Explore the ADME properties, challenges and practices, and case studies like Inclisiran and T-DM1. Learn how WuXi AppTec DMPK's expertise in complex molecules, high-throughput assays, well-established platforms, and global regulatory support de-risks development and streamlines timelines.
Speaker
Dr. Michael Gassen
With a career spanning over two decades in the life science industry including leadership roles at Merck Germany, Nuvisan, and Envigo where he's made significant contributions to pharmacology, drug metabolism, and analytical chemistry, Dr. Michael Gassen has partnered with WuXi AppTec Laboratory Testing Division since 2017. His work emphasizes innovative solutions in DMPK and pharmacology models, steering discovery, and preclinical development projects to Phase I submissions. His expertise extends across strategic R&D collaborations, business strategy execution, and scientific/regulatory consulting. Dr. Gassen earned a Ph.D. in Organic Chemistry from Würzburg University, Germany, focusing on lipid peroxidation derived toxic aldehydes.
Location
The View in Biopartner 5
7 De Limes 2342 DH Oegstgeest Netherlands
Agenda
11:00
Welcome
Accelerating RNA Editing Technology Development Through Collaborative Efforts
Seda Yilmaz-Elis, Director of Discovery Research ProQR
Integrated Solutions and Research Strategies for TPD Molecules
Lingbing Sun, Head TPD Discovery, WuXi Biology
Advancing Oligonucleotide Therapeutics Discovery and Development
Qiong Zhou, Executive Director, WuXi Biology
12:00 - 12:30
Beyond Small Molecules – DMPK for New Modalities
Michael Gassen, Senior Advisor and SME, WuXi AppTec
12:30 - 14:00
Lunch Buffet
Related Services and Platforms
-
In Vitro ADME ServicesLearn More
-
In Vivo PharmacokineticsLearn More
-
MetID (Metabolite Profiling and Identification)Learn More
-
Radiolabeled In Vivo ADME StudyLearn More
-
DMPK BioanalysisLearn More
-
Physicochemical Property StudyLearn More
-
Permeability and Transporter StudyLearn More
-
Drug Distribution and Protein Binding StudiesLearn More
-
Metabolic Stability StudyLearn More
-
Drug Interactions StudyLearn More
-
Rodent PK StudyLearn More
-
Large Animal (Non-Rodent) PK StudyLearn More
-
Clinicopathological Testing Services for Laboratory AnimalsLearn More
-
High-Standard Animal Facilities and Animal WelfareLearn More
-
Preclinical Formulation ScreeningLearn More
-
In Vitro MetID (Metabolite Profiling and Identification)Learn More
-
In Vivo MetID (Metabolite Profiling and Identification)Learn More
-
Metabolite Biosynthesis and Structural CharacterizationLearn More
-
Metabolites in Safety Testing (MIST)Learn More
-
Radiolabeled MetID (Metabolite Profiling and Identification)Learn More
-
Radiolabeled Non-Clinical In Vivo ADME StudyLearn More
-
Quantitative Whole-body Autoradiography (QWBA)Learn More
-
Human Radiolabeled Mass Balance StudyLearn More
-
Radiolabeled Compound SynthesisLearn More
-
Novel Drug Modalities BioanalysisLearn More
-
Small Molecules BioanalysisLearn More
-
Bioanalytical Instrument PlatformLearn More
Stay Connected
Keep up with the latest news and insights.
